Wegovy Dose Lower Than Mounjaro? Compare UK Prices

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy vs Mounjaro UK - Compare Prices

Compare Wegovy and Mounjaro at the cheapest UK price from £124.99 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Why Is Wegovy Dose Lower Than Mounjaro? Understanding Dosage Differences

Many patients ask why Wegovy dose lower than Mounjaro when comparing these two leading weight loss injections. The answer lies in their different active ingredients and mechanisms: Wegovy contains semaglutide with a maximum dose of 2.4mg weekly, whilst Mounjaro contains tirzepatide reaching up to 15mg weekly. These aren't directly comparable milligram-for-milligram because they work through different receptor pathways, and clinical trials demonstrate both achieve significant weight loss at their respective therapeutic doses.

Understanding Why Wegovy Dose Lower Than Mounjaro in Milligrams

The numerical difference in Wegovy dose lower than Mounjaro reflects fundamental differences in molecular structure and potency, not treatment effectiveness. Semaglutide (Wegovy) is a GLP-1 receptor agonist requiring 2.4mg weekly to achieve optimal therapeutic effect, whilst tirzepatide (Mounjaro) is a dual GIP/GLP-1 receptor agonist with a maximum maintenance dose of 15mg weekly [1]. These medications cannot be compared by milligram alone because their receptor binding affinities and pharmacokinetic profiles differ substantially.

In the STEP 1 trial, Wegovy at 2.4mg weekly produced an average weight loss of 14.9% over 68 weeks, whilst the SURMOUNT-1 trial showed Mounjaro 15mg achieved 20.9% average weight loss over 72 weeks [2]. However, both medications demonstrate clinical efficacy at their respective licensed doses, and the lower milligram amount in Wegovy does not indicate reduced potency. Our clinical team at Cured Pharmacy frequently explains to patients that dose comparison requires understanding receptor pharmacology, not simple numerical comparison.

The escalation schedules also differ significantly: Wegovy increases from 0.25mg to 2.4mg over 16-20 weeks, whilst Mounjaro escalates from 2.5mg to 15mg over a similar timeframe [3]. This graduated approach minimises gastrointestinal side effects whilst allowing the body to adapt to each medication's mechanism. Patients switching between treatments require careful clinical assessment by our UK-registered prescribers to ensure appropriate dosing transitions.

Wegovy Dose Lower Than Mounjaro: Different Mechanisms Explained

The reason Wegovy dose lower than Mounjaro in numerical terms relates directly to their receptor targeting strategies. Semaglutide activates only GLP-1 receptors with extremely high binding affinity, achieving maximal therapeutic effect at 2.4mg weekly. Tirzepatide activates both GIP and GLP-1 receptors, requiring higher milligram dosing to effectively engage both pathways simultaneously [4].

GLP-1 receptor activation reduces appetite, slows gastric emptying, and improves glycaemic control. Mounjaro's additional GIP receptor activity may enhance fat metabolism and insulin sensitivity beyond GLP-1 alone, potentially explaining the higher average weight loss observed in head-to-head comparisons [5]. However, individual response varies considerably, and some patients achieve excellent results with Wegovy's lower-dose GLP-1-only approach, particularly when gastrointestinal tolerability is a concern.

Receptor Binding and Clinical Efficacy

Despite Wegovy dose lower than Mounjaro numerically, semaglutide demonstrates approximately 95% GLP-1 receptor occupancy at therapeutic doses, representing near-maximal receptor activation [6]. Tirzepatide's dual-agonist design requires higher milligram dosing to achieve balanced GIP and GLP-1 activation, but this doesn't necessarily translate to proportionally greater benefits for all patients. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), emphasises that treatment selection should consider individual tolerance, medical history, and treatment goals rather than focusing solely on milligram differences.

Should You Switch If Wegovy Dose Lower Than Mounjaro?

Patients often wonder whether switching from Wegovy to Mounjaro makes sense given that Wegovy dose lower than Mounjaro in milligrams. The decision requires clinical assessment considering current weight loss progress, side effect profile, and treatment goals. If you've achieved satisfactory results on Wegovy 2.4mg weekly, switching may not provide additional benefit and could introduce new side effects during the transition period.

Clinical data suggests switching may be appropriate for patients who have plateaued on maximum-dose Wegovy or require additional glycaemic control for type 2 diabetes management [7]. However, transitioning between GLP-1 medications requires careful prescriber supervision to manage the washout period and dose escalation appropriately. At Cured Pharmacy, our UK-registered clinical team conducts thorough assessments before approving any treatment switches, ensuring patient safety and optimal outcomes.

Cost considerations also factor into switching decisions. Wegovy is available from £124.99 at Cured Pharmacy with competitive UK pricing, whilst Mounjaro starts from £124.99 reflecting its dual-agonist formulation. Patients should discuss with their prescriber whether the potential additional weight loss with Mounjaro justifies the higher investment, particularly if Wegovy is already producing meaningful results.

Transition Protocol Between Treatments

When switching from Wegovy to Mounjaro despite Wegovy dose lower than Mounjaro, most prescribers recommend starting Mounjaro at the 2.5mg dose after the final Wegovy injection has cleared (typically 4-5 weeks given semaglutide's half-life). This conservative approach minimises overlapping GLP-1 activity and reduces gastrointestinal side effects. Patients should never combine both medications simultaneously without explicit prescriber approval, as this significantly increases adverse event risk.

Treatment Active Ingredient Maximum Dose Mechanism Starting Price
Wegovy Semaglutide 2.4mg weekly GLP-1 agonist From £89.00
Mounjaro Tirzepatide 15mg weekly Dual GIP/GLP-1 agonist From £145.00
Saxenda Liraglutide 3mg daily GLP-1 agonist From £68.00
Wegovy Oral Semaglutide 50mg daily GLP-1 agonist (oral) From £83.00

Wegovy Dose Lower Than Mounjaro: Safety and Side Effect Profiles

Although Wegovy dose lower than Mounjaro numerically, both medications share similar side effect profiles dominated by gastrointestinal symptoms including nausea, diarrhoea, constipation, and vomiting [8]. These effects typically diminish over time as the body adapts to treatment. Some patients find Wegovy's lower-dose GLP-1-only mechanism better tolerated than Mounjaro's dual-agonist approach, whilst others experience the opposite.

Serious adverse events remain rare with both treatments but include potential pancreatitis, gallbladder disease, and thyroid C-cell tumours (observed in rodent studies). The MHRA and NHS emphasise that both medications require careful patient selection, excluding those with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Our clinical team at Cured Pharmacy conducts comprehensive medical history reviews during the online consultation process to identify any contraindications before prescribing.

The graduated dose escalation with both medications helps mitigate side effects, but the fact that Wegovy dose lower than Mounjaro doesn't necessarily mean fewer adverse events. Individual tolerance varies, and some patients tolerate higher-dose tirzepatide better than lower-dose semaglutide. This underscores the importance of personalised treatment selection under UK prescriber supervision.

Clinical Evidence: Wegovy Dose Lower Than Mounjaro Impact on Results

Direct comparison trials examining whether Wegovy dose lower than Mounjaro affects weight loss outcomes show tirzepatide producing approximately 5-6 percentage points greater average weight loss at maximum doses. The SURMOUNT-1 trial demonstrated 20.9% average weight loss with Mounjaro 15mg versus 14.9% with Wegovy 2.4mg in the STEP 1 trial, though these were separate studies with different populations [2].

However, these averages mask substantial individual variation. Approximately 35% of Wegovy patients achieved ≥20% weight loss in clinical trials, demonstrating that lower milligram dosing doesn't preclude excellent outcomes for many individuals. Treatment response depends on multiple factors including baseline weight, metabolic health, lifestyle modifications, and genetic factors influencing GLP-1 receptor sensitivity.

NICE guidance recognises both medications as clinically effective for weight management in appropriate patients, without favouring one over the other based solely on dose differences. The choice between Wegovy and Mounjaro should consider the complete clinical picture, not just the numerical dose disparity. Our pharmacists help patients understand these nuances during the consultation process, ensuring informed treatment decisions.

Long-Term Weight Maintenance Considerations

Evidence suggests that despite Wegovy dose lower than Mounjaro, both medications require ongoing treatment to maintain weight loss, with significant regain observed after discontinuation [7]. This reflects the chronic nature of obesity and the ongoing metabolic effects of GLP-1 pathway modulation. Patients should view either medication as a long-term commitment rather than a short-term intervention, with treatment duration determined by individual response and tolerability under prescriber guidance.

Accessing Wegovy and Mounjaro: Wegovy Dose Lower Than Mounjaro Price Comparison

Understanding that Wegovy dose lower than Mounjaro helps contextualise the UK pricing landscape. At Cured Pharmacy, Wegovy is available from £124.99 with our competitive pricing guarantee, representing excellent value for a clinically proven GLP-1 treatment. New patients Save £20 off their first order using code Weightlossnew, making treatment initiation more accessible.

Both medications require prescription following online clinical assessment by our UK-registered prescribers. The consultation process takes under 3 minutes and evaluates medical history, current medications, and treatment suitability. We provide transparent upfront pricing before consultation, ensuring patients understand costs before committing to assessment. All medications dispensed are genuine UK-licensed products from registered wholesalers, never grey market imports.

Our discreet packaging and next-day delivery service ensure convenient access to treatment without pharmacy visits. As a GPhC-registered pharmacy (9012511) operating under superintendent pharmacist Tarun Kumar's oversight, we maintain the highest standards of pharmaceutical care whilst offering the lowest prices guaranteed in the UK. Patients can contact our clinical team on (+44) 116 4646009 for any questions regarding treatment selection, dosing, or the differences between Wegovy and Mounjaro.

Scientific References

  1. Frias, J. P., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  2. Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  3. Wilding, J. P., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  4. Nauck, M. A., & D'Alessio, D. A. (2022). Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovascular Diabetology, 21(1), 169. [accessed 15 August 2026]
  5. Müller, T. D., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72-130. [accessed 15 August 2026]
  6. Lau, J., et al. (2015). Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry, 58(18), 7370-7380. [accessed 15 August 2026]
  7. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
  8. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Medicines and Healthcare products Regulatory Agency. [accessed 15 August 2026]
  9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Why is Wegovy dose lower than Mounjaro in milligrams?
Wegovy dose lower than Mounjaro because semaglutide has higher GLP-1 receptor binding affinity, achieving maximal effect at 2.4mg weekly, whilst tirzepatide's dual GIP/GLP-1 mechanism requires 15mg weekly for optimal activation of both pathways.
Does Wegovy being a lower dose mean it's less effective than Mounjaro?
No, the lower milligram dose doesn't indicate reduced effectiveness. Clinical trials show Wegovy produces significant weight loss (average 14.9%), though Mounjaro achieved slightly higher results (20.9%) in separate studies, with substantial individual variation in both.
Can I switch from Wegovy to Mounjaro if the dose seems lower?
Switching is possible but requires clinical assessment by a UK prescriber. The decision should be based on your current progress, tolerability, and treatment goals rather than dose numbers alone, with appropriate washout periods observed.
Is Wegovy safer because the dose is lower than Mounjaro?
Both medications have similar safety profiles with comparable side effect rates. The dose difference reflects different mechanisms rather than safety variations, and individual tolerability varies regardless of milligram amounts.
How much does Wegovy cost compared to Mounjaro in the UK?
Wegovy is available from £124.99 at Cured Pharmacy, whilst Mounjaro starts from £124.99, reflecting the different formulations and manufacturing processes involved in each treatment.
Will I lose more weight on Mounjaro because the dose is higher?
Clinical trial averages suggest Mounjaro produces approximately 5-6% greater weight loss, but individual results vary widely. Many patients achieve excellent outcomes on Wegovy's lower dose, and treatment selection should consider multiple factors beyond average results.
Do I need a prescription for Wegovy or Mounjaro?
Yes, both are prescription-only medicines requiring clinical assessment by a UK-registered prescriber. Cured Pharmacy provides free online consultations taking under 3 minutes, with same-day approval for suitable candidates.
Can I take both Wegovy and Mounjaro together for better results?
No, combining GLP-1 medications is not recommended and significantly increases adverse event risk. Patients should use only one treatment at a time under prescriber supervision, never self-combining medications.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.